RMD

#413
ResMed Inc.
230.6500 USD
+0.64%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
229.4750
230.6800
Jahresspanne
218.4400
277.6700
Tagesänderung
+0.64%
Monatliche Änderung
+0.01%
6 month change
-10.95%
Jahresänderung
-10.95%
Vorheriger Schlusskurs
229.1800
Eröffnung
230.0650
Bid
Ask
Tief
229.4750
High
230.6800
Volumen
877
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 33.6007 B
  • Employee 11 K
  • Founded N/A
  • CEO Michael J. Farrell
  • Website www.resmed.com
  • Headquarter Delaware, United States
  • FIGI BBG000L4M7F1
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
27.13
Preis-Umsatz-Verhältnis
7.39
Dividende je Aktie
2.12
Dividendenrendite in %
0.82

ResMed Inc

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.

Nachrichten